ProSciento

Chula Vista, CA, USA Specialty Founded 2012 51-200 employees

Specialty CRO focused on cardiometabolic clinical trials. Operates Phase 1–2 studies for obesity, diabetes, NASH/MASH, and cardiovascular endpoints with proprietary biomarker platforms.

Services

PRECLINICAL

PK/ADME Studies

CLINICAL

Phase I Clinical Trials Phase II Clinical Trials Biostatistics

ANALYTICAL

Bioanalytical Testing

Therapeutic Areas

Metabolic Cardiovascular Endocrinology

Contact

Locations

Chula Vista, CA

Certifications

GCP Compliant FDA Registered

Regulatory Experience

FDAEMA